{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:52:44Z","timestamp":1791550364206,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004087","name":"Shizuoka University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004087","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014424","name":"Meiji University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014424","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008702","name":"Kagoshima University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008702","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajpmfocus.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AJPM Focus"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.focus.2026.100517","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T15:50:51Z","timestamp":1779465051000},"page":"100517","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of Green Tea Gargling on COVID-19: A Multicenter RCT"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7711-425X","authenticated-orcid":false,"given":"Yasue","family":"Kawai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1563-8782","authenticated-orcid":false,"given":"Yoshihiko","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1702-9278","authenticated-orcid":false,"given":"Takahiro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Furushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuina","family":"Nakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoyasu","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1132-8154","authenticated-orcid":false,"given":"Shinya","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Unno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoriyuki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norikata","family":"Takuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takatsugu","family":"Ikukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuo","family":"Kimata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chika","family":"Tagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6562-2295","authenticated-orcid":false,"given":"Masaki","family":"Ichitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3463-5237","authenticated-orcid":false,"given":"Takanobu","family":"Takihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Kinugasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.focus.2026.100517_bib0001","unstructured":"WHO COVID-19 dashboard. World Health Organization. https:\/\/data.who.int\/dashboards\/covid19\/cases?n=c. Updated May 17, 2026. Accessed October 24, 2025."},{"issue":"10359","key":"10.1016\/j.focus.2026.100517_bib0002","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/S0140-6736(22)01585-9","article-title":"The Lancet Commission on lessons for the future from the COVID-19 pandemic","volume":"400","author":"Sachs","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.focus.2026.100517_bib0003","unstructured":"Underlying conditions and the higher risk for severe COVID-19. U.S. Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/covid\/hcp\/clinical-care\/underlying-conditions.html. Updated February 6, 2025. Accessed December 9, 2025."},{"key":"10.1016\/j.focus.2026.100517_bib0004","unstructured":"World Health Organization. Tracking SARS-CoV-2 variants. https:\/\/www.who.int\/activities\/tracking-SARS-CoV-2-variants. Accessed December 9, 2025."},{"issue":"8","key":"10.1016\/j.focus.2026.100517_bib0005","doi-asserted-by":"crossref","first-page":"e482","DOI":"10.1016\/S1473-3099(24)00415-8","article-title":"Virological characteristics of the SARS-CoV-2 KP.3, LB.1, and KP.2.3 variants","volume":"24","author":"Kaku","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.focus.2026.100517_bib0006","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.amjmed.2023.04.040","article-title":"Prolonged symptoms after COVID-19 in Japan: a nationwide survey of the symptoms and their impact on patients\u2019 quality of life","volume":"138","author":"Honda","year":"2025","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.focus.2026.100517_bib0007","first-page":"416","article-title":"Post-coronavirus disease 2019 syndrome in Japan: an observational study using a medical database","volume":"6","author":"Kinugasa","year":"2023","journal-title":"JMA J"},{"key":"10.1016\/j.focus.2026.100517_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1195908","article-title":"Effectiveness of SARS-CoV-2 vaccines against Omicron infection and severe events: a systematic review and meta-analysis of test-negative design studies","volume":"11","author":"Song","year":"2023","journal-title":"Front Public Health"},{"key":"10.1016\/j.focus.2026.100517_bib0009","doi-asserted-by":"crossref","first-page":"ofad240","DOI":"10.1093\/ofid\/ofad240","article-title":"Effectiveness of BA.1- and BA.4\/BA.5-containing bivalent COVID-19 mRNA vaccines against symptomatic SARS-CoV-2 infection during the BA.5-dominant period in Japan","volume":"10","author":"Arashiro","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.focus.2026.100517_bib0010","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1186\/s12889-022-13667-y","article-title":"The effectiveness of hand hygiene interventions for preventing community transmission or acquisition of novel coronavirus or influenza infections: a systematic review","volume":"22","author":"Gozdzielewska","year":"2022","journal-title":"BMC Public Health"},{"key":"10.1016\/j.focus.2026.100517_bib0011","article-title":"COVID-19 prevalence, risk perceptions, and preventive behavior in asymptomatic Latino population: a cross-sectional study","volume":"12","author":"Karout","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.focus.2026.100517_bib0012","article-title":"Effectiveness of wearing masks during the COVID-19 outbreak in cohort and case-control studies: a systematic review and meta-analysis","volume":"49","author":"Floriano","year":"2023","journal-title":"J Bras Pneumol"},{"issue":"5","key":"10.1016\/j.focus.2026.100517_bib0013","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00637-20","article-title":"Effectiveness of face masks in preventing airborne transmission of SARS-CoV-2","volume":"5","author":"Ueki","year":"2020","journal-title":"mSphere"},{"issue":"1","key":"10.1016\/j.focus.2026.100517_bib0014","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13756-021-01049-9","article-title":"Systematic review on factors influencing the effectiveness of alcohol-based hand rubbing in healthcare","volume":"11","author":"Price","year":"2022","journal-title":"Antimicrob Resist Infect Control"},{"issue":"3","key":"10.1016\/j.focus.2026.100517_bib0015","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ajic.2020.08.020","article-title":"Inactivation of SARS-CoV-2 by commercially available alcohol-based hand sanitizers","volume":"49","author":"Leslie","year":"2021","journal-title":"Am J Infect Control"},{"issue":"8","key":"10.1016\/j.focus.2026.100517_bib0016","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1056\/NEJMc2215471","article-title":"Effectiveness of bivalent boosters against severe omicron infection","volume":"388","author":"Lin","year":"2023","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.focus.2026.100517_bib0017","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.amepre.2005.06.013","article-title":"Prevention of upper respiratory tract infections by gargling: a randomized trial","volume":"29","author":"Satomura","year":"2005","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.focus.2026.100517_bib0018","series-title":"Tea as a Food Ingredient Properties, Processing, and Health Aspects","first-page":"127","article-title":"Tea polyphenols for the prevention of influenza and the common cold","author":"Tominaga","year":"2022"},{"issue":"1","key":"10.1016\/j.focus.2026.100517_bib0019","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-43563-3","article-title":"Effects of tea, catechins and catechin derivatives on Omicron subvariants of SARS-CoV-2","volume":"13","author":"Shin-Ya","year":"2023","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.focus.2026.100517_bib0020","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3390\/pathogens10060721","article-title":"Rapid inactivation in vitro of SARS-CoV-2 in saliva by black tea and green tea","volume":"10","author":"Ohgitani","year":"2021","journal-title":"Pathogens"},{"issue":"12","key":"10.1016\/j.focus.2026.100517_bib0021","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.3390\/molecules26123572","article-title":"Significant inactivation of SARS-CoV-2 in vitro by a green tea catechin, a catechin-derivative, and black tea galloylated theaflavins","volume":"26","author":"Ohgitani","year":"2021","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.focus.2026.100517_bib0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0271112","article-title":"Epigallocatechin gallate (EGCG) attenuates severe acute respiratory coronavirus disease 2 (SARS-CoV-2) infection by blocking the interaction of SARS-CoV-2 spike protein receptor-binding domain to human angiotensin-converting enzyme 2","volume":"17","author":"Ohishi","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.focus.2026.100517_bib0023","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13578-021-00680-8","article-title":"Epigallocatechin gallate from green tea effectively blocks infection of SARS-CoV-2 and new variants by inhibiting spike binding to ACE2 receptor","volume":"11","author":"Liu","year":"2021","journal-title":"Cell Biosci"},{"issue":"17","key":"10.1016\/j.focus.2026.100517_bib0024","doi-asserted-by":"crossref","first-page":"9498","DOI":"10.3390\/ijms25179498","article-title":"The inhibiting effect of GB-2, (+)-catechin, theaflavin, and theaflavin 3-gallate on interaction between ACE2 and SARS-CoV-2 EG.5.1 and HV.1 variants","volume":"25","author":"Lu","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.focus.2026.100517_bib0025","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2217\/fvl-2022-0184","article-title":"Structure-based virtual identification of natural inhibitors of SARS-CoV-2 and its Delta and Omicron variant proteins","volume":"18","author":"Alanzi","year":"2023","journal-title":"Future Virol"},{"issue":"1","key":"10.1016\/j.focus.2026.100517_bib0026","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-026-41170-6","article-title":"Pyrogallol B-ring enhances catechin binding to the SARS-CoV-2 spike receptor-binding domain to inhibit interaction with ACE2","volume":"16","author":"Matsumoto","year":"2026","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.focus.2026.100517_bib0027","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1186\/s12885-024-12228-3","article-title":"Phase I\/II clinical trial of efficacy and safety of EGCG oxygen nebulization inhalation in the treatment of COVID-19 pneumonia patients with cancer","volume":"24","author":"Yin","year":"2024","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.focus.2026.100517_bib0028","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/covid1010002","article-title":"Efficacy of a polyphenolic, standardized green tea extract for the treatment of COVID-19 syndrome: a proof-of-principle study","volume":"1","author":"Bettuzzi","year":"2021","journal-title":"COVID"},{"issue":"7","key":"10.1016\/j.focus.2026.100517_bib0029","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1248\/bpb.b24-00113","article-title":"An exploratory randomized controlled study to investigate concentration-dependence of green tea catechin gargling on acute upper respiratory tract infections","volume":"47","author":"Tominaga","year":"2024","journal-title":"Biol Pharm Bull"},{"issue":"6","key":"10.1016\/j.focus.2026.100517_bib0030","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3999\/jscpt.44.459","article-title":"Gargling with green tea for influenza prophylaxis: a pilot clinical study","volume":"44","author":"Toyoizumi","year":"2013","journal-title":"Jpn J Clin Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.focus.2026.100517_bib0031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096373","article-title":"Effects of green tea gargling on the prevention of influenza infection in high school students: a randomized controlled study","volume":"9","author":"Ide","year":"2014","journal-title":"PLoS One"},{"issue":"1\u20132","key":"10.1016\/j.focus.2026.100517_bib0032","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0021-9673(96)00456-6","article-title":"Simultaneous analysis of individual catechins and caffeine in green tea","volume":"749","author":"Goto","year":"1996","journal-title":"J Chromatogr A"},{"issue":"9","key":"10.1016\/j.focus.2026.100517_bib0033","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.3390\/nu13093024","article-title":"Investigation of the oral retention of tea catechins in humans: an exploratory interventional study","volume":"13","author":"Furushima","year":"2021","journal-title":"Nutrients"}],"container-title":["AJPM Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S277306542600043X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S277306542600043X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:00:53Z","timestamp":1791547253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S277306542600043X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S277306542600043X"],"URL":"https:\/\/doi.org\/10.1016\/j.focus.2026.100517","relation":{},"ISSN":["2773-0654"],"issn-type":[{"value":"2773-0654","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Green Tea Gargling on COVID-19: A Multicenter RCT","name":"articletitle","label":"Article Title"},{"value":"AJPM Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.focus.2026.100517","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100517"}}